(Z)-3-(4-ethoxyphenyl)-2-(2-(2-oxoindolin-3-ylidene)hydrazinyl)quinazolin-4(3H)-one

ID: ALA4291306

Chembl Id: CHEMBL4291306

PubChem CID: 145988494

Max Phase: Preclinical

Molecular Formula: C24H19N5O3

Molecular Weight: 425.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccc(-n2c(N/N=C3\C(=O)Nc4ccccc43)nc3ccccc3c2=O)cc1

Standard InChI:  InChI=1S/C24H19N5O3/c1-2-32-16-13-11-15(12-14-16)29-23(31)18-8-4-6-10-20(18)26-24(29)28-27-21-17-7-3-5-9-19(17)25-22(21)30/h3-14H,2H2,1H3,(H,26,28)(H,25,27,30)

Standard InChI Key:  JXDORVZJUKKONH-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4291306

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckbr Cholecystokinin B receptor (729 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckbr Cholecystokinin B receptor (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.45Molecular Weight (Monoisotopic): 425.1488AlogP: 3.55#Rotatable Bonds: 5
Polar Surface Area: 97.61Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.93CX Basic pKa: 2.57CX LogP: 4.05CX LogD: 4.05
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.48Np Likeness Score: -1.18

References

1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M..  (2017)  Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.,  (7): [PMID:30108868] [10.1039/C7MD00171A]

Source